Profile
ABVC VRTX REGN VRNA ARGX ALNY
Company Name ABVC BioPharma, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $24.63M $122.53B $81.42B $72.68B $51.58B $43.35B
Employees 0.02K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Uttam Yashwant Patil Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
ABVC VRTX REGN VRNA ARGX ALNY
Quant Rating Score 1 4 4 1 4 3
Quant Rating Strong Sell Buy Buy Strong Sell Buy Neutral
Trading
ABVC VRTX REGN VRNA ARGX ALNY
Last Close $2.9 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $4.76 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $0.41 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -39.08 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 607.32 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
ABVC VRTX REGN VRNA ARGX ALNY
1 Month Return -0.68 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return -7.35 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return 95.95 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return 451.33 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return 391.53 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return 452.17 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABVC VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) - 9.76 % 3.92 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Growth
ABVC VRTX REGN VRNA ARGX ALNY
Asset Growth -3.14 % 7.41 % 53.91 % 10.71 %
Gross Profit Growth 440.11 % 1.16 % - 26.81 %
Revenue Growth 234.31 % 0.99 % - 22.97 %
Revenue 3 Year -69.26 % 20.64 % -15.89 % 147.1 %
Revenue 5 Year -89.11 % 73.64 % - 775.72 %
Revenue 10 Year - 285.02 % - 2487.4 %
EBIT Growth 32.3 % 9.09 % -131.37 % 24.59 %
Net Income Growth 37.05 % 2.09 % -224.78 % 36.82 %
Net Income 3 Yeari Growth Per Share 91.8 % 6.32 % -148.34 % 69.73 %
Net Income 5 Yeari Growth Per Share 79.82 % 31.91 % 25.82 % 73.13 %
Net Income 10 Yeari Growth Per Share -273.45 % 680.22 % -35.51 % 55.09 %
Operating Income Growth 30.47 % -7.46 % -133.02 % 37.31 %
Operating Cash Flow Growth (CFG) 56.79 % - -143.33 % -107.98 %
Operating 3 Year CFG 94.89 % -100 % -170.73 % 98.8 %
Operating 5 Year CFG 91.35 % -100 % 54.81 % 97.44 %
Operating 10 Year CFG -13043.77 % -100 % 40.15 % 97.08 %
EPS Growth 76.67 % 5.31 % -214.81 % 38.07 %
EPS Diluted Growth 76.67 % 8.19 % -208.93 % 38.07 %
Book Value Per Share -78.55 % 32.88 % -22.82 % 129.75 %
Share Holder 3 Year Equity Growth Per Share -97.02 % 41.21 % 1.82 % -89.42 %
Share Holder 5 Year Equity Growth Per Share 221.74 % 191.63 % -24.45 % -96.01 %
Share Holder 10 Year Equity Growth Per Share 913.68 % 842.11 % -71.86 % -95.83 %
Dividend Per Share Growth - - - -
Dividend 3 Year Growth Per Share - - - -
Dividend 5 Year Growth Per Share - - - -
Dividend 10 Year Growth Per Share - - - -
Debt Growth 15.72 % 0.06 % 139.05 % 110.16 %
Free Cash Flow Growth 57.01 % - -144.48 % -201.54 %
Updated On 31 Dec 2024 31 Dec 2025 31 Dec 2024 31 Dec 2024
Profitability
ABVC VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM 100 % 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -19.44 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM -64.06 % 21.81 % 14.83 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM -30.61 % 19.59 % 10.3 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 93.31 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 98.24 % 111.4 % 146.19 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM -562.79 % 34.06 % 24.95 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM -148.13 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM - 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM - 0.4 2.1 2.37 0.9 4.37
Inventory Turnover TTM - 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM 6.42 % 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM 3.77 % 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -0.09 14.55 48.39 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -0.09 13.06 39.66 -0.85 5.58 1.68
Cash Per Share TTM 1.11 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM -258.28 % 31.71 % 34.71 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 89.76 % 81.96 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM -148.13 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -11.95 36.72 19.95 -995.27 129.37 195.85
Price To Operating Cash Flows Ratio TTM -19.18 32.86 16.2 -126.33 146.05 162.25
Price Cash Flow Ratio TTM -19.18 32.86 16.2 -126.33 146.05 162.25
Income Statement (TTM)
ABVC VRTX REGN VRNA ARGX ALNY
Revenue $0B $12B $14.34B $0.03B $2.19B $3.71B
Gross Profit $0B $10.35B $12.24B $0.03B $1.96B $3.04B
Gross Profit Ratio 99.85% 86.24% 85.35% 93.89% 89.62% 81.77%
EBITDA $-0B $4.69B $5.82B $-0.12B $0.11B $0.56B
Net Income $-0B $3.95B $4.5B $-0.14B $0.83B $0.31B
EPS Diluted -0.42 15.32 41.48 -1.73 12.78 2.33
Balance Sheet (MRQ)
ABVC VRTX REGN VRNA ARGX ALNY
Long Term Debt $0B $3.69B $2.71B $0.12B $0.03B $2.7B
Total Liabilities $0.01B $6.98B $9.3B $0.27B $0.7B $4.18B
Total Equity $0B $18.67B $31.26B $0.2B $5.5B $0.79B
Total Investments $0B $5.71B $15.75B $0.02B $1.93B $1.25B
Total Debt $0B $3.69B $2.71B $0.12B $0.04B $2.97B
Total Assets $0.01B $25.64B $40.56B $0.47B $6.2B $4.97B
Cash Flow Statement (TTM)
ABVC VRTX REGN VRNA ARGX ALNY
Net Income $-0.01B $3.95B $4.5B $-0.17B $0.83B $0.31B
Inventory $0B $-0.52B $-0.28B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $-0B $3.63B $4.98B $-0.12B $-0.08B $0.52B
Capital Expenditure $0B $-0.44B $-0.9B $-0B $-0.07B $-0.06B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 24.69
AARD Aardvark Therapeutics, Inc. Common Stock 12.14
ABCL AbCellera Biologics Inc. 3.111
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.005
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.505
ABPWW 0.0131
ABSI Absci Corporation 2.545
ABUS Arbutus Biopharma Corporation 3.99
ABVX Abivax SA American Depositary Shares 124.925
ACAD ACADIA Pharmaceuticals Inc. 22.04
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 6.84
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.205
ACIU AC Immune SA 2.98
ACLX Arcellx, Inc. 68.55
ETFs With Exposure to ABVC
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 336.66
VXF Vanguard Extended Market Index Fund 0.00049 216.22
IWC iShares Micro-Cap ETF 0 166.14
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00049 162.32
DFSU Dimensional US Sustainability Core 1 ETF 0.00038845 43.45
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00049 162.33
DCOR Dimensional ETF Trust 0.00034068 75.47
VEMPX Vanguard Extended Market Index InstlPlus 0.00049 400.57
Unlock